179 related articles for article (PubMed ID: 28659656)
1. Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation.
Daley-Brown D; Oprea-Iles G; Vann KT; Lanier V; Lee R; Candelaria PV; Quarshie A; Pattillo R; Gonzalez-Perez RR
Dis Markers; 2017; 2017():8248175. PubMed ID: 28659656
[TBL] [Abstract][Full Text] [Related]
2. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance.
Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR
World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531
[TBL] [Abstract][Full Text] [Related]
3. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
Guo S; Gonzalez-Perez RR
PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
[TBL] [Abstract][Full Text] [Related]
4. NILCO biomarkers in breast cancer from Chinese patients.
Colbert LS; Wilson K; Kim S; Liu Y; Oprea-Ilies G; Gillespie C; Dickson T; Newman G; Gonzalez-Perez RR
BMC Cancer; 2014 Apr; 14():249. PubMed ID: 24716804
[TBL] [Abstract][Full Text] [Related]
5. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
6. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
[TBL] [Abstract][Full Text] [Related]
7. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.
McCampbell AS; Mittelstadt ML; Dere R; Kim S; Zhou L; Djordjevic B; Soliman PT; Zhang Q; Wei C; Hursting SD; Lu KH; Broaddus RR; Walker CL
Curr Mol Med; 2016; 16(3):252-65. PubMed ID: 26917264
[TBL] [Abstract][Full Text] [Related]
8. Squash cytodiagnosis of synchronous papillary serous carcinoma of ovary and endometrium with demonstration of serous tubal intraepithelial carcinoma as a precursor lesion.
Kar A; Kar T; Dha I; Panda S
Indian J Pathol Microbiol; 2017; 60(1):125-127. PubMed ID: 28195111
[No Abstract] [Full Text] [Related]
9. The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
Marinelli O; Morelli MB; Annibali D; Aguzzi C; Zeppa L; Tuyaerts S; Amantini C; Amant F; Ferretti B; Maggi F; Santoni G; Nabissi M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751388
[TBL] [Abstract][Full Text] [Related]
10. [II. Endometrial neoplasms 1. Papillary serous carcinoma].
Nakayama K; Miyazaki K
Gan To Kagaku Ryoho; 2012 Feb; 39(2):190-3. PubMed ID: 22545285
[No Abstract] [Full Text] [Related]
11. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.
Lipsey CC; Harbuzariu A; Daley-Brown D; Gonzalez-Perez RR
World J Methodol; 2016 Mar; 6(1):43-55. PubMed ID: 27019796
[TBL] [Abstract][Full Text] [Related]
12. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.
Zhang L; Liu Y; Hao S; Woda BA; Lu D
Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514
[TBL] [Abstract][Full Text] [Related]
13. Differences in treatment and outcome between African-American and white women with endometrial cancer.
Randall TC; Armstrong K
J Clin Oncol; 2003 Nov; 21(22):4200-6. PubMed ID: 14615448
[TBL] [Abstract][Full Text] [Related]
14. Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells.
Carino C; Olawaiye AB; Cherfils S; Serikawa T; Lynch MP; Rueda BR; Gonzalez RR
Int J Cancer; 2008 Dec; 123(12):2782-90. PubMed ID: 18798554
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Lysine-Specific Demethylase 1 Is Associated With Tumor Progression and Unfavorable Prognosis in Chinese Patients With Endometrioid Endometrial Adenocarcinoma.
Liu YD; Dai M; Yang SS; Xiao M; Meng FL; Chen XW
Int J Gynecol Cancer; 2015 Oct; 25(8):1453-60. PubMed ID: 26166558
[TBL] [Abstract][Full Text] [Related]
16. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
18. A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.
Morrison C; Miecznikowski J; Darcy KM; Dolce JM; Kandel E; Erwin DO; Liu S; Shepherd L; Cohn D; McMeekin DS; Block AW; Nowak NJ; Maxwell L
Genes Chromosomes Cancer; 2010 Sep; 49(9):791-802. PubMed ID: 20607851
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
[TBL] [Abstract][Full Text] [Related]
20. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]